preloader

2803(E)

(Published in Part II, Section 3, Sub-section (ii) of

the Gazette of India, Extraordinary, dated the 27th November, 2008)

Government of India

Ministry of Chemicals and Fertilizers

National Pharmaceutical Pricing Authority

New Delhi, the 27th November, 2008

ORDER

S.O. 2803(E)- In exercise of the powers, conferred by sub-paragraph (1)/(2)/(4) of paragraph 8 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637 (E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority, hereby fixes/revises the prices as specified in column (5) of the table hereto annexed as the retail price/revised retail price, exclusive of excise duty, Sales Taxes/VAT and local taxes, if any, and in column (6) as equivalent MRP inclusive of excise duty, education cess, Sales Tax/VAT in relation to each of the formulation specified in the corresponding entry in column (2) of the said table with the pack size specified in the corresponding entries in column (3) thereof; manufactured/imported by M/s. Pfizer Products India Pvt. Ltd.

TABLE

 

Sl.  No. Name of the    formulation  Pack  Size Existing     Retail  Price    Excise (Rs.)   Retail Price   without     Excise  Duty  Sales Tax /VAT     and Local Tax, if any (Rs.) Equivalent MRP*  inclusive  of all taxes (Rs.)
(1) (2) (3) (4) (5) (6)
1    Solu Medrol AOV 500 mg         Each ml containsethyl Prednisolone Sodium Succinate – 500 mg   Batch No. OATJ4 / Qty. 23576 Vials imported  4ml Vial 568.82 596.09 619.93
2 Solu Medrol AOV 1000 mg   Each ml containsMethyl Prednisolone Sodium Succinate – 1000 mgBatch No. OATXC / Qty. 29637 Vials imported  Batch No. OAWHS / Qty. 33640 Vials imported   8ml Vial 911.76 967.11 1005.79
3 Depo – Medrol 80 mg             Each ml containsMethyl Prednisolone Acetate – 80 mgBatch No. R05744 / Qty. 160070 Vials imported Batch No. R05897 / Qty. 160000 Vials imported 2mlVial 77.41 77.73 80.83
4 Solo Medrol AOV 40 mg Injection   Each Vials contains       Methyl Prednisolone Sodium Succinate –  40 mgBatch No. R04764/ Qty. 86898 Vials imported 1mlVial 128.86 132.76 138.07
5 Solu-Medrol AOVEach Vials contains  Methyl Prednisolone Sodium Succinate – 125mg   Batch No. R05169/ Qty. 73324 Vials 2mlVial 246.02 252.46 262.56
6 Medrol Tablets         Each tablet contains      Methyl Prednisolone –  4 mgBatch No. H641P / Qty. 20772 Strip importedBatch No. H723A / Qty. 27490 Strip imported 10×10’s   Strip/Blister 312.39 324.14 337.11
7 Medrol Tablet             Each tablet contains  Methyl Prednisolone –  16 mg    Batch No. H751A / Qty. 47520 Strip imported   Batch No. H751A / Qty. 51718 Strip imported  14’s         Strip/Blister 137.52 142.41 148.11

 

*Subject to actual payment of Government levies/taxes, as applicable.

Note :

(a)        The prices fixed are the maximum retail prices in column no. (6) (inclusive of excise duty, sales tax/VAT and local taxes if any) for the specified pack and packs of similar strength, and companies cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.

(b)        The companies / manufacturers may added taxes only if they have paid actually to the Government on the price mentioned in the column (5).  If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in the Form-V of DPCO, 1995.

(c)        For different packing material used or any special feature claimed, companies are required to approach NPPA for approval/fixation of specific prices.

(d)        The manufacturer and marketing company for the above said formulation shall be required to take the requisite prior approval from the competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.

(e)        These prices/revised prices shall be made effective within 15 days of receipt of this order as required under sub para 14(1) of DPCO, 1995. The necessary price-list should also be issued as required under sub-paragraph (3) of paragraph 14 of the Drugs (Prices Control) Order, 1995.

 (f)        These prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.

PN/105/2008/F

   F. No. 8(14)/2008/D.P./NPPA-Div.-II

                                                                                                              (RAJIV WADHAWAN)

                                                                                                                     Deputy Director

Last Page Updated: 01-06-2019